Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingjing Qu

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Scientific Data|July 18, 2025
A Global Dataset Mapping the AI Innovation from Academic Research to Industrial PatentsHaixing Gong, Hui Zou, Xingzhou Liang, et al.
Frontiers in Oncology|July 11, 2022
Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E MutationJingjing Qu, Qian Shen, Yuping Li, et al.
Stem Cell Research & Therapy|August 4, 2021
Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicineLijun Chen, Jingjing Qu, Quanhui Mei, et al.
Discover Oncology|June 25, 2026
Clinical outcomes of concomitant anti-PD-1 therapy and denosumab treatment in non-small cell lung cancer patients with bone metastasis: a single-center retrospective studyMengjiao Fu, Ninghu Liu, Jingjing Qu, et al.
Heliyon|October 17, 2022
Study on chronic toxicity of rhubarb extract in Sprague-Dawley ratsWenxiang Yang, Ji Liu, Yanhua Zheng, et al.
JCI Insight|January 19, 2017
Oxidized CaMKII promotes asthma through the activation of mast cellsJingjing Qu, Danh C Do, Yufeng Zhou, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2021
Subchronic oral toxicity study of rhubarb extract in Sprague-Dawley ratsChunxia Liu, Ji Liu, Yanhua Zheng, et al.
Journal of Oncology|October 6, 2022
Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World StudyJingjing Qu, Farhin Shaheed Kalyani, Qian Shen, et al.
Cellular and Molecular Life Sciences : CMLS|February 21, 2022
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applicationsLijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Frontiers in Oncology|July 12, 2021
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective StudyLi Liu, Farhin Shaheed Kalyani, Haiyan Yang, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Scientific Data|July 18, 2025
A Global Dataset Mapping the AI Innovation from Academic Research to Industrial PatentsHaixing Gong, Hui Zou, Xingzhou Liang, et al.
Frontiers in Oncology|July 11, 2022
Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E MutationJingjing Qu, Qian Shen, Yuping Li, et al.
Stem Cell Research & Therapy|August 4, 2021
Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicineLijun Chen, Jingjing Qu, Quanhui Mei, et al.
Discover Oncology|June 25, 2026
Clinical outcomes of concomitant anti-PD-1 therapy and denosumab treatment in non-small cell lung cancer patients with bone metastasis: a single-center retrospective studyMengjiao Fu, Ninghu Liu, Jingjing Qu, et al.
Heliyon|October 17, 2022
Study on chronic toxicity of rhubarb extract in Sprague-Dawley ratsWenxiang Yang, Ji Liu, Yanhua Zheng, et al.
JCI Insight|January 19, 2017
Oxidized CaMKII promotes asthma through the activation of mast cellsJingjing Qu, Danh C Do, Yufeng Zhou, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2021
Subchronic oral toxicity study of rhubarb extract in Sprague-Dawley ratsChunxia Liu, Ji Liu, Yanhua Zheng, et al.
Journal of Oncology|October 6, 2022
Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World StudyJingjing Qu, Farhin Shaheed Kalyani, Qian Shen, et al.
Cellular and Molecular Life Sciences : CMLS|February 21, 2022
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applicationsLijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Frontiers in Oncology|July 12, 2021
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective StudyLi Liu, Farhin Shaheed Kalyani, Haiyan Yang, et al.
Pageof 8